help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leav, I.
Right arrow Articles by Ho, S.-m.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leav, I.
Right arrow Articles by Ho, S.-m.
(American Journal of Pathology. 1999;154:863-870.)
© 1999 American Society for Investigative Pathology


Regular Articles

Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions

Irwin Leav* , Frederick B. Merk* , Kai Fai Lee{dagger} , Massimo Loda{ddagger} , Mira Mandoki{ddagger} , John E. McNeal§ and Shuk-mei Ho{dagger}

From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology,{dagger} Tufts Unversity, Medford, Massachusetts, the Department of Pathology,{ddagger} Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California

In situ hybridization and immunohistochemistry were used to localize and compare the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult prostate. Results were then compared with hyperplastic, dysplastic, and neoplastic lesions. Both receptor message and protein were predominately localized in epithelial cells of the fetal, neonatal, prepubertal, and normal adult prostate. In hyperplastic lesions the expression of the receptor was unchanged with respect to normal epithelial cells. Irrespective of grade, markedly enhanced expression of the receptor was evident in dysplastic lesions. In lower Gleason grade carcinomas the intensity of receptor signal at the message and protein levels approximated that found in normal prostatic epithelium. However, in foci within higher grade cancers, receptor expression appeared diminished. Results from our study suggest that prolactin action plays a role in the development and maintenance of the human prostate and may also participate in early neoplastic transformation of the gland. Diminution of receptor expression in high grade neoplasms could reflect the emergence of a population of cells that are no longer responsive to the peptide hormone.





This article has been cited by other articles:


Home page
Cancer Res.Home page
V. V. Levina, B. Nolen, Y. Su, A. K. Godwin, D. Fishman, J. Liu, G. Mor, L. G. Maxwell, R. B. Herberman, M. J. Szczepanski, et al.
Biological Significance of Prolactin in Gynecologic Cancers
Cancer Res., June 15, 2009; 69(12): 5226 - 5233.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. N. Lauber and N. J. Gooderham
The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer
Cancer Res., October 1, 2007; 67(19): 9597 - 9602.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. Goffin, S. Bernichtein, P. Touraine, and P. A. Kelly
Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists
Endocr. Rev., May 1, 2005; 26(3): 400 - 422.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N Berteaux, S Lottin, E Adriaenssens, F Van Coppenolle, X Leroy, J Coll, T Dugimont, and J-J Curgy
Hormonal regulation of H19 gene expression in prostate epithelial cells
J. Endocrinol., October 1, 2004; 183(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Li, T. J. Ahonen, K. Alanen, J. Xie, M. J. LeBaron, T. G. Pretlow, E. L. Ealley, Y. Zhang, M. Nurmi, B. Singh, et al.
Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade
Cancer Res., July 15, 2004; 64(14): 4774 - 4782.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. G. Robertson, J. Harris, M. J. Naylor, S. R. Oakes, J. Kindblom, K. Dillner, H. Wennbo, J. Tornell, P. A. Kelly, J. Green, et al.
Prostate Development and Carcinogenesis in Prolactin Receptor Knockout Mice
Endocrinology, July 1, 2003; 144(7): 3196 - 3205.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Harkonen
Paracrine Prolactin May Cause Prostatic Problems
Endocrinology, June 1, 2003; 144(6): 2266 - 2268.
[Full Text] [PDF]


Home page
Cancer Res.Home page
J. Kim, W. Luo, D.-T. Chen, K. Earley, J. Tunstead, L.-Y. Yu-Lee, and S.-H. Lin
Antitumor Activity of the 16-kDa Prolactin Fragment in Prostate Cancer
Cancer Res., January 15, 2003; 63(2): 386 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. A. Feldman, C. Longcope, C. A. Derby, C. B. Johannes, A. B. Araujo, A. D. Coviello, W. J. Bremner, and J. B. McKinlay
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 589 - 598.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
L.-Y. Yu-Lee
Prolactin Modulation of Immune and Inflammatory Responses
Recent Prog. Horm. Res., January 1, 2002; 57(1): 435 - 455.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Ahonen, P. L. Harkonen, H. Rui, and M. T. Nevalainen
PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro
Endocrinology, January 1, 2002; 143(1): 228 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Untergasser, H. Rumpold, E. Plas, M. Witkowski, and P. Berger
Seminal Plasma Factors Induce in Vitro PRL Secretion in Smooth Muscle Cells of the Human Prostate
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5577 - 5584.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Taplin and S.-M. Ho
The Endocrinology of Prostate Cancer
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477.
[Full Text] [PDF]


Home page
EndocrinologyHome page
S. J. McPherson, H. Wang, M. E. Jones, J. Pedersen, T. P. Iismaa, N. Wreford, E. R. Simpson, and G. P. Risbridger
Elevated Androgens and Prolactin in Aromatase-Deficient Mice Cause Enlargement, But Not Malignancy, of the Prostate Gland
Endocrinology, June 1, 2001; 142(6): 2458 - 2467.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Kline, H. Roehrs, and C. V. Clevenger
Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor
J. Biol. Chem., December 10, 1999; 274(50): 35461 - 35468.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. E. Stoker, C. L. Robinette, B. H. Britt, S. C. Laws, and R. L. Cooper
Prepubertal Exposure to Compounds That Increase Prolactin Secretion in the Male Rat: Effects on the Adult Prostate
Biol Reprod, December 1, 1999; 61(6): 1636 - 1643.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. B. Kline and C. V. Clevenger
Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk
J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.